BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16990195)

  • 21. Ambulatory intragastric pH monitoring: clinical laboratory to clinical practice.
    Katz PO
    Rev Gastroenterol Disord; 2003; 3 Suppl 4():S3-9. PubMed ID: 14671508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Influence of Helicobacter pylori on gastroesophageal reflux disease].
    Mieczysława CS; Monika P
    Pol Merkur Lekarski; 2007 Dec; 23(138):449-53. PubMed ID: 18432130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton pump inhibitors for dyspepsia.
    Vakil N
    Dig Dis; 2008; 26(3):215-7. PubMed ID: 18463438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review article: trials on reflux disease -- the role of acid secretion and inhibition.
    Sonnenberg A
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():2-8; discussion 38-9. PubMed ID: 15456457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in proton pump inhibitors and management of acid-peptic disorders.
    Jain KS; Shah AK; Bariwal J; Shelke SM; Kale AP; Jagtap JR; Bhosale AV
    Bioorg Med Chem; 2007 Feb; 15(3):1181-205. PubMed ID: 17150362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Helicobacter pylori and gastroesophageal reflux disease: Protective, aggressive or innocent bystander?].
    Pellicano R
    Minerva Gastroenterol Dietol; 2000 Mar; 46(1):67-70. PubMed ID: 19320080
    [No Abstract]   [Full Text] [Related]  

  • 27. [The best strategies against reflux disease. Acid stomach and the sequelae].
    Füessl HS
    MMW Fortschr Med; 2004 Oct; 146(44):4-6. PubMed ID: 15566236
    [No Abstract]   [Full Text] [Related]  

  • 28. The pathophysiologic basis for epidemiologic trends in gastroesophageal reflux disease.
    Pandolfino JE; Kwiatek MA; Kahrilas PJ
    Gastroenterol Clin North Am; 2008 Dec; 37(4):827-43, viii. PubMed ID: 19028320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors.
    Raghunath AS; Hungin AP; Mason J; Jackson W
    Aliment Pharmacol Ther; 2009 Feb; 29(4):431-9. PubMed ID: 19035981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicobacter pylori and non-malignant diseases.
    Rokkas T; Simsek I; Ladas S
    Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
    Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
    J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review article: the clinical influence of Helicobacter pylori in effective acid suppression-implications for the treatment of gastro-oesophageal reflux disease.
    Martínek J; Kuzela L; Spicák J; Vavrecka A
    Aliment Pharmacol Ther; 2000 Aug; 14(8):979-90. PubMed ID: 10930891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nocturnal gastric acid breakthrough on proton pump inhibitors.
    Savarino V; Mela GS
    Aliment Pharmacol Ther; 1999 Jul; 13(7):977-8. PubMed ID: 10383534
    [No Abstract]   [Full Text] [Related]  

  • 34. H. pylori-infected gastroesophageal reflux disease patients harbor less virulent strains.
    Fallone CA; Barkun AN
    Am J Gastroenterol; 2002 Apr; 97(4):1065. PubMed ID: 12003394
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevalence of celiac disease, Helicobacter pylori and gastroesophageal reflux in patients with refractory iron deficiency anemia.
    Fayed SB; Aref MI; Fathy HM; Abd El Dayem SM; Emara NA; Maklof A; Shafik A
    J Trop Pediatr; 2008 Feb; 54(1):43-53. PubMed ID: 17908698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with gastroesophageal junction adenocarcinoma in Japan.
    Koike T; Ohara S; Inomata Y; Abe Y; Iijima K; Shimosegawa T
    Inflammopharmacology; 2007 Apr; 15(2):61-4. PubMed ID: 17450443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Choosing one PPI treatment over another.
    Dachs R; Darby-Stewart A; Graber M
    Am Fam Physician; 2007 Nov; 76(9):1273-4. PubMed ID: 18019869
    [No Abstract]   [Full Text] [Related]  

  • 38. Helicobacter pylori infection and gastroesophageal reflux in a population-based study (The HUNT Study).
    Nordenstedt H; Nilsson M; Johnsen R; Lagergren J; Hveem K
    Helicobacter; 2007 Feb; 12(1):16-22. PubMed ID: 17241296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helicobacter pylori, obesity and gastro-oesophageal reflux disease. Is there a relation? A personal view.
    Loffeld RJ
    Neth J Med; 2005 Oct; 63(9):344-7. PubMed ID: 16244381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helicobacter pylori and reflux disease.
    McColl KE; Gillen D
    Lancet; 2001 Nov; 358(9294):1730; author reply 1730-1. PubMed ID: 11728579
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.